Actos Prostate Cancer Lawsuit Evaluation
UPDATE 10/3/2011: Potential cases for prostate cancer from Actos are no longer being actively pursued or reviewed.
The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the United States who have been diagnosed with bladder cancer from Actos, a popular type 2 diabetes drug that the FDA has linked to a potential risk of bladder tumors when used for long periods of time. As part of our review and evaluation of these cases, we are now also considering whether individuals may be entitled to compensation through an Actos lawsuit if they were diagnosed with prostate cancer.
At this time, there have been no FDA warnings about the risk of prostate cancer from Actos. However, our law firm has a good faith basis to suspect that there may be an association between Actos and prostate cancer, which the manufacturer may have failed to adequately research or warn about.
Prostate cancer is a form of cancer that develops in the prostate gland of the male reproductive system. While most cancer of the prostate is slow growing, in some cases it can be an aggressive cancer and cells may spread to other parts of the body.
While early prostate cancer usually causes no symptoms, it can lead to problems like:
- Painful Urination
- Blood in the Urine
- Difficulty Urinating or Frequent Urination
- Difficulty During Sexual Intercourse
- Erectile Dysfunction
While the investigation is in its very early stages, our lawyers are evaluating whether there may be a basis for Actos prostate cancer lawsuits. Any cases being investigated for individuals diagnosed with prostate cancer are being reviewed “for investigation only” at this point, but there are never any fees or expenses unless our Actos lawyers are ultimately successful obtaining compensation.
UPDATE 10/3/2011: Potential cases for prostate cancer from Actos are no longer being actively pursued or reviewed.
